60% Of Japanese Patients Believe Cancer Drug Costs Too High
This article was originally published in PharmAsia News
Executive Summary
Over half of Japanese patients feel the pain of the high costs of cancer drugs and insulin treatment, reported a recent survey conducted by Japan Federation of Democratic Medical Institution (Minyiren)